Decreased copy numbers or null genotype of GSTM1 have been associated with hepatotoxicity [31] and higher risk of many cancers including lung cancer [32], gastric cancer [33], and bladder cancer [34]. The gene discussed is GSTM1; the disease is urinary bladder cancer.